COMMUNIQUÉS West-GlobeNewswire

-
Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia
21/08/2019 -
Pre-Clinical Evidence Confirms Veyonda® Abscopal Effect
21/08/2019 -
Progressive Care Inc. Reports Record Revenue of $3.4 Million for July 2019
21/08/2019 -
Cocrystal Pharma Announces Abstract Accepted for Oral Presentation at the ISIRV: Options X for the Control of Influenza Conference
21/08/2019 -
Fear of Rejection is Transplant Patient’s Top Concern
21/08/2019 -
BioCardia Reports 2019 Second Quarter Financial Results and Business Highlights
21/08/2019 -
HempAmericana Launches North American CBD Sales Force Following Successful Inventory Build
21/08/2019 -
CURE Pharmaceutical [OTCQB: CURR] Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms
21/08/2019 -
Altimmune Announces $3.7 Million in Additional BARDA Funding to Advance NasoShield™ Clinical Development
21/08/2019 -
Cara Therapeutics Enters into Commercial License Agreement with Enteris BioPharma, Inc. for Peptelligence® Oral Formulation Technology
21/08/2019 -
Pluristem Therapeutics to Host Key Opinion Leader Call on its Acute Radiation Syndrome and Hematological Deficiencies Programs
21/08/2019 -
YSS Corp. Announces Second Quarter 2019 Results and Operational Update
21/08/2019 -
Tonix Pharmaceuticals and Massachusetts General Hospital Enter into Research Collaboration to Develop Tonix’s Third Generation Anti-CD154 Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Organ Transplant Rejection
21/08/2019 -
RedHill Biopharma Announces Acceptance of Oral Presentations on RHB-105 (H. pylori) and RHB-104 (Crohn’s Disease) Phase 3 Data at ACG 2019 Annual Scientific Meeting
21/08/2019 -
Sharps Compliance Reports Fiscal 2019 Fourth Quarter Results
21/08/2019 -
Teleflex to Present at the Wells Fargo Securities 2019 Healthcare Conference
21/08/2019 -
Cerecor Receives Fast Track Designation from FDA for CERC-802 for the Treatment of Mannose-Phosphate Isomerase Deficiency
21/08/2019 -
Tetra Bio-Pharma Announces Joint Venture with Thorne and Onegevity Health to Form CB2 Therapeutics
21/08/2019 -
Orphazyme Interim Report First Half 2019 Presentation
21/08/2019
Pages